Chronic Inflammation: The Evidence-Based Supplement Protocol

← Back to articles

"Chronic inflammation" is a syndrome label rather than a single diagnosis, but elevated CRP, IL-6, and TNF-α reliably predict cardiovascular, metabolic, and neurodegenerative disease risk. Several supplements have trial evidence for lowering these inflammatory biomarkers in adults with metabolic syndrome, autoimmune conditions, or cardiovascular risk factors. None of them substitute for the lifestyle drivers — body composition, sleep, exercise, stress, and diet — which produce vastly larger effects.

EPA-Dominant Omega-3, 2–3 g EPA + DHA Daily

Omega-3 reduces hsCRP modestly across pooled trials. The 2024 meta-analysis pooling 56 RCTs found a 0.4 mg/L average hsCRP reduction at ≥2 g daily over ≥8 weeks. Effect is largest in adults with elevated baseline CRP and metabolic syndrome. The REDUCE-IT cardiovascular benefit at 4 g icosapent ethyl is partly attributable to inflammation reduction. See our omega-3 in mood/inflammation piece.

Curcumin (Bioavailable Form), 500 mg Daily

A 2018 meta-analysis of 9 RCTs of bioavailable curcumin (Meriva, Theracurmin, BCM-95, or with piperine) showed significant reductions in serum hsCRP, IL-6, and TNF-α versus placebo at 8–12 weeks. The effect requires a bioavailable formulation — plain turmeric powder fails. See our curcumin absorption piece.

Vitamin D to Repletion (Serum 25-OH-D 30–50 ng/mL)

Vitamin D deficiency is associated with elevated inflammatory markers in observational data. Repletion in deficient adults modestly reduces CRP and IL-6 in some RCTs, though VITAL and other large primary-prevention trials in already-replete adults have been null. Treat the deficiency, not the level. See our vitamin D piece.

Polyphenol Load — Hydroxytyrosol (EVOO), Anthocyanins, Cocoa Flavanols

The Mediterranean-diet PREDIMED trial showed inflammatory marker improvements driven significantly by the high-polyphenol EVOO arm. Supplementation pathways: 30 mL high-polyphenol EVOO daily delivers ~30 mg hydroxytyrosol; cocoa flavanols 400–500 mg daily lowers CRP modestly; anthocyanin-rich berry intake (or 320 mg standardized blueberry/elderberry extract) has small but reproducible CRP signals. See our EVOO piece.

What NOT to Take

Avoid antioxidant megadoses — see our megadose myth piece. The CARET and ATBC trials both showed harm from supraphysiologic antioxidant intake. Skip "anti-inflammatory" detox blends entirely. Avoid combining curcumin with anticoagulants without monitoring — modest platelet effects. Don't replace NSAIDs in active inflammatory disease with supplements alone.

How to Run the Protocol

Get baseline hsCRP, 25-OH-D, and lipid panel. Address the lifestyle layer first: weight, sleep, exercise, no smoking, low alcohol. Supplement omega-3 2 g + curcumin 500 mg + EVOO 30 mL daily. Repleat vitamin D if low. Re-test hsCRP at 12 weeks; meaningful reduction is 25–30%. Persistent CRP elevation despite the protocol warrants rheumatology or cardiology evaluation. See the heart health stack for the related cardiovascular context.